AP2004003136A0
(en )
2004-09-30
Virus-like particles of human papillomavirus
AU2003248721A1
(en )
2004-01-06
Adsorbents, methods of preparation, and methods of use thereof
AU2003227533A1
(en )
2003-09-29
Virus like particle from papillomavirus and their use in vaccine
AU2003217870A1
(en )
2003-09-16
Pini-modulating compounds and methods of use thereof
AU2003225669A1
(en )
2004-04-19
Pin1-modulating compounds and methods of use thereof
AU2003225668A1
(en )
2003-09-16
Pin1-modulating compounds and methods of use thereof
AU2003223207A1
(en )
2003-09-16
SCDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003275311A1
(en )
2004-04-30
Solid micro-perforators and methods of use
AU2003213673A1
(en )
2003-09-16
Pin1-modulating compounds and methods of use thereof
AU2003235676A1
(en )
2003-07-30
Tricyclic-bis-enone derivatives and methods of use thereof
AU2003298998A1
(en )
2004-04-08
Oriented nanostructures and methods of preparing
EP1664348B8
(en )
2019-06-12
Detection of hpv
TWI349557B
(en )
2011-10-01
Use of hpv 16 and hpv 18 vlps for vaccine preparation
AU2003275056A1
(en )
2004-04-08
Novel lapacho compounds and methods of use thereof
AU2003290012A1
(en )
2004-06-30
L2-peptide of the human papillomavirus associated with virus-like particles
AU2003286395A1
(en )
2004-06-23
Process for the preparation of cabr2 hydrates and uses thereof
AU2003248879A1
(en )
2004-01-23
RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003287802A1
(en )
2004-06-15
Palpometer and methods of use thereof
GB0200258D0
(en )
2002-02-20
Detection of human papillomavirus
GB0201382D0
(en )
2002-03-13
Virus-like particles
AU2003207941A1
(en )
2003-07-30
Pigment epithelium derived factor from human plasma and methods of use thereof
AUPR790901A0
(en )
2001-10-18
Inactivation of papillomavirus
AU2003208314A1
(en )
2003-09-22
Novel application of vaccination against tnf-alpha
AU2002236065A1
(en )
2002-09-19
Papillomavirus vaccines
HK1072378A
(en )
2005-08-26
Virus-like particles of human papillomavirus